In episode 138 I dive into two of my recent publications. In the first clinical trial I discuss how we used the technique of metabolomics to quantify the plasma oxylipidome. Here we link smoking status to peripheral artery disease with the oxylipidome. In the second study, we provide evidence that genetics may play a role in the propensity for nicotine addiction, cigarette smoking, and lung disease. Good science is never accomplished alone but as part of a great collaborative team. I thank my contributors and collaborators for their hard work and input to both of these studies. Tune in for the scientific details!
Want to buy me a coffee to say thanks for the episode? You can do so via Venmo or Patreon below.
Venmo ID: Steph-Cal
Patreon: https://www.patreon.com/join/DrSCaligiuri
https://www.buymeacoffee.com/drscaligiuri
Follow me on social media to see the papers I cite in this week's episode:
IG: Dr.SCaligiuri
FB: ThePeoplesScientist
Twitter: DrSCaligiuri
Linkedin: Stephanie Caligiuri
TikTok: Dr.SCaligiuri
Hosted on Acast. See acast.com/privacy for more information.
